End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
68.4 CNY | -1.08% | +6.18% | -12.53% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The company benefits from high valuations in earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-12.53% | 7.5B | B- | ||
-1.09% | 12.72B | B+ | ||
+0.45% | 5.48B | B | ||
-1.37% | 4.61B | C | ||
+5.16% | 4.47B | C | ||
-51.93% | 3.28B | D+ | ||
+11.34% | 2.71B | - | - | |
-19.05% | 2.02B | B- | ||
-11.07% | 1.74B | D+ | ||
-6.06% | 1.69B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 300832 Stock
- Ratings Shenzhen New Industries Biomedical Engineering Co., Ltd.